Gapping down
In reaction to earnings/guidance:
- ICAD -5.7% (sees Q4 revs below consensus)
Other news:
- AVRO -13.4% (is shifting its portfolio priorities to focus on other clinical-stage programs and extending its cash runway into the first quarter of 2024)
- CNM -8.4% (stock offering)
- SE -6.9% (will hold its annual general meeting of shareholders on February 14; proposal will be submitted to the AGM for shareholders to approve as a special resolution)
- AFCG -5.4% (launches 3 mln share public offering)
- WMG -4% (announces sale of 8.56 mln shares by Access Industries)
- SBTX -2.1% (files for $250 mln mixed securities shelf offering)
Analyst comments:
- FL -4.2% (downgraded to Underweight from Neutral at JP Morgan)
- TROW -2.6% (downgraded to Sell from Neutral at Goldman)
- PINS -2.4% (downgraded to Neutral from Buy at Guggenheim)
- SLQT -1.8% (downgraded to In-line from Outperform at Evercore ISI)
- APAM -1.5% (downgraded to Neutral from Buy at Goldman)
- AQUA -1.5% (downgraded to Mkt Perform from Outperform at Raymond James)
- BLL -1.3% (downgraded to Neutral from Buy at Citigroup)
- STNE -1.2% (downgraded to Neutral from Buy at UBS),